SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (374)11/13/2001 5:02:27 AM
From: SemiBull  Respond to of 415
 
Some PR via the NYTimes today:

"Other companies are already aiming at certain aspects of bacterial behavior. Essential Therapeutics of Waltham, Mass., which until a merger last month was known as Microcide Pharmaceuticals (news/quote), is trying to design drugs to disable tiny pumps that bacteria use to eject antibiotics."

THE DRUG MAKERS: Antibiotics Business Is Again Popular
nytimes.com